EphrinB2 upregulation after RT was also confirmed in our MOC2 HNSCC tumor model, and ephrinB2-expressing vascular cells were observed to be more proliferative as determined by Ki-67 expression (Supplementary Fig. 6B, C). The gene discussed is EFNB2; the disease is neoplasm.